BridgeMD
New treatment option for Stroke
Official title Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2)
ClinicalTrials.gov ID: NCT04119544
What this study is testing
- What it's testing
- Hemiparesis is a common motor disorder after a stroke. The majority of patients do not recover functional use of their paretic upper limb.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Age ≥18 years;
- Stroke hemiparesis on unilateral focal lesion dating from 4 to 10 weeks at baseline;
- Total sub-scores wrist and hand of th Fugl-Meyer \< 16
- Patient having agreed to sign an informed consent
- patient being affiliated to the French Social Security
You likely can't join if
- Cognitive dysfunction or progressive intercurrent illness making effective communication or participation in the study impossible
- Phasic disorders that prevent the understanding of instructions
- Patient include in an other clinical trial
- Neurological conditions prior to stroke
- Patient who had mirror therapy or IVS rehabilitation before inclusion
- Rheumatological pathology of the hand and wrist
See the full eligibility criteria
- Age ≥18 years;
- Stroke hemiparesis on unilateral focal lesion dating from 4 to 10 weeks at baseline;
- Total sub-scores wrist and hand of th Fugl-Meyer \< 16
- Patient having agreed to sign an informed consent
- patient being affiliated to the French Social Security
- Cognitive dysfunction or progressive intercurrent illness making effective communication or participation in the study impossible
- Phasic disorders that prevent the understanding of instructions
- Patient include in an other clinical trial
- Neurological conditions prior to stroke
- Patient who had mirror therapy or IVS rehabilitation before inclusion
- Rheumatological pathology of the hand and wrist
- Person under legal protection measure.
The study team makes the final eligibility decision.
Where it's taking place
- Reims, Champagne-Ardenne, France
- Saint-Paul-lès-Dax, New Aquitaine, France
- Boissise-le-Roi, France
- Cosne-Cours-sur-Loire, France
- Villiers-sur-Orge, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Reims, Champagne-Ardenne, France; Saint-Paul-lès-Dax, New Aquitaine, France; Boissise-le-Roi, France; Cosne-Cours-sur-Loire, France; Villiers-sur-Orge, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.